APY Aspyra,

Aspyra, Inc. (AMEX: APY) today announced plans to offer customers volume-based pricing for its AccessNET PACS and AccessRAD RIS/PACS solutions at the upcoming RSNA 2008 Annual Meeting held at McCormick Place in Chicago, IL (November 30 � December 4, 2008), Booth 6610, South Building Hall A. Aspyra�s AccessNET PACS and AccessRAD RIS/PACS provide affordable solutions for the cost-conscious hospital, imaging center and orthopedic group practice. Maintaining the same product functionality and scalability, Aspyra has adapted the new volume-based pricing to accommodate the financial constraints facing today�s healthcare organizations. With the new volume-based pricing model, customers can �pay-as-they-grow�, with lower upfront and long-term costs based on study volume. Included in the volume-based pricing model are unlimited radiology, diagnostic and clinical user licenses, as well as unlimited DICOM connections, further protecting healthcare organizations from future unanticipated costs as they grow their business. Aspyra will also offer its existing customers a program to convert from traditional pricing to the new volume-based structure, or remain on their existing pricing model. Rob Pruter, Aspyra�s Senior Vice President of Sales and Marketing states, �Aspyra provides healthcare organizations with flexible solutions which are reflected in our new volume-based pricing and All-in-One PACS and RIS/PACS solutions. These financially sensible models enable our customers to invest in sophisticated solutions that are aligned with their business growth plans.� To learn more about Aspyra and its products, visit Booth 6610, South Hall at RSNA from November 30 � December 4, 2008. Aspyra�s PACS, Specialty PACS and RIS/PACS solutions are designed to meet the needs of acute care hospitals, enterprise-wide delivery networks,medium to large imaging centers,and orthopedic group practices, with end-to-end solutions that automate processes at every point of patient and imaging encounter workflow. About Aspyra Aspyra is a global provider of Health Care Information Technology (HCIT) solutions and services to the healthcare industry. The Company specializes in Clinical Information Systems (CIS), Picture Archive Communication Systems (PACS) and Clinical Image Management Systems (CIMS) for hospitals, multi-specialty clinics, clinical laboratories, imaging departments and centers and orthopedic environments. Aspyra's highly scalable systems can be installed standalone or integrated to provide a single-vendor, enterprise-wide solution. For more information on Aspyra, its products and services, visit www.aspyra.com. Safe Harbor Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management as of the date of this release, including management's own knowledge and assessment of the Company's industry, customers and competition. Factors that could cause Aspyra's actual results to differ materially from these forward-looking statements include among others: changes in the Company�s management or other personnel, the competitive environment for Company products and services; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in the Company�s long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.